International Congress Munich 2014


The more in-depth classification of lung cancer: relevance for patients and science

Hot topics
Chairs: R.M. Huber (Munich, Germany), G. Massard (Strasbourg, France)
Aims: The session will present:
- rationale for the new classification of lung cancer and elimination of the term bronchioloalveolar carcinoma;
- understanding the different classifications and the concept of predominant subtypes;
- integration of the major genetic alterations;
- and consequences for lung cancer management and research.
Integration of molecular testing in the classification of NSCLC: the French experience
A. Cortot (Lille, France)
Slide presentationWebcastMultimedia files
Slide presentationWebcastMultimedia files
Prognostic relevance of the new lung cancer classification in operable stages
P. Schnabel (Meckesheim, Germany)
Slide presentationWebcastMultimedia files
Slide presentationWebcastMultimedia files
Relevance of a more precise classification in Japan and Asia
Y. Nakanishi (Fukuoka, Japan)
Slide presentation
Slide presentation
Lung cancer classification and characterisation in daily practice of thoracic oncology
E. Quoix (Strasbourg, France)
Slide presentation
Slide presentation